Reduced responsiveness of cutaneous microcirculation in essential hypertension - A pilot study

Blood Pressure

Volumn 15, Issue 5, 2006, Pages 275-280

  Lindstedt, Isak ^a   Edvinsson, Marie Louise ^a   Evinsson, Lars ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acetylcholine; CGRP; Endothelial dysfunction; Hypertension; Iontophoresis; Sodium nitroprusside

Indexed keywords

ACETYLCHOLINE; ALDOSTERONE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; AUTACOID; CALCITONIN GENE RELATED PEPTIDE; CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROPRUSSIDE SODIUM; POTASSIUM; RENIN; SODIUM; SOLUBLE INTERLEUKIN 2 RECEPTOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; URIC ACID;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAM; ENDOTHELIAL DYSFUNCTION; ESSENTIAL HYPERTENSION; FEMALE; FOREARM BLOOD FLOW; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; LIFESTYLE; MALE; MICROCIRCULATION; PATHOGENESIS; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN BLOOD FLOW; STIMULUS RESPONSE; VASODILATATION; WARMING;

ACETYLCHOLINE; ADULT; CALCITONIN GENE-RELATED PEPTIDE; CASE-CONTROL STUDIES; FEMALE; FOREARM; HEAT; HUMANS; HYPERTENSION; MALE; MICROCIRCULATION; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PILOT PROJECTS; SKIN; VASODILATION;

EID: 33847223816     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08037050600996586     Document Type: Article

References (26)

1. Taddei, S. (2001) Endothelial dysfunction in hypertension. J Cardiovasc Pharmacol, 38, pp. S11-S14.
2. Puddu, P., Puddu, G. M., Zaca, F. and Muscari, A. (2000) Endothelial dysfunction in hypertension. Acta Cardiol, 55, pp. 221-232.
3. Martin, H., Hu, J., Gennser, G. and Norman, M. (2000) Impaired endothelial function and increased carotid stiffness in 9-year-old children with low birth weight. Circulation, 102, pp. 2739-2744.
4. Creager, M. A., Cooke, J. P., Mendelsohn, M. E., Gallagher, S. J., Coleman, S. M. and Loscalzo, J. (1990) Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest, 86, p. 228.
5. Tesfamariam, B. and Halpern, W. (1998) Endothelium-dependent and endothelium-independent vasodilation in resistance arteries from hypertensive rats. Hypertension, 11, pp. 440-444.
6. Cardillo, C. (2002) Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension. Circulation, 105, pp. 452-456.
7. Andersson, S. E., Edvinsson, M. L., Alving, K. and Edvinsson, L. (2005) Vasodilator effect of endothelin in cutaneous microcirculation of heart failure patients. Basic Clin Pharmacol & Toxicol, 97, pp. 80-85.
8. Carberry, P. A., Shepherd, A. M. M. and Johnson, J. M. (1992) Resting and maximal forearm SkBF are reduced in hypertension. Hypertension, 20, pp. 349-355.
9. Uddman, R., Edvinsson, L., Ekblad, E., Hakanson, R. and Sundler, F. (1986) Calcitonin gene-related peptide (CGRP): Perivascular distribution and vasodilatory effects. Regul Pept, 15, pp. 1-23.
10. Dipette, D. J., Schwarzenberger, K., Kerr, N. and Holland, O. B. (1989) Dose dependent systemic and regional hemodynamic effects of calcitonin gene-related peptide. Am J Med Sci, 297, pp. 65-70.
11. Yamada, M., Ishikawa, T., Fujimori, A., Miyauchi, T. and Goto, K. (1998) Enhanced depressor and hyperaemic responses to calcitonin gene-related peptide in spontaneously hypertensive rats. Peptides, 19, pp. 697-701.
12. Supowit, S. C., Zhao, H. and Dipette, D. J. (2001) Nerve growth factor enhances calcitonin gene-related peptide expression in the spontaneously hypertensive rat. Hypertension, 37, pp. 728-732.
13. Lind, H. and Edvinsson, L. (2002) Enhanced vasodilator responses to calcitonin gene-related peptide (CGRP) in subcutaneous arteries in human hypertension. J Hum Hypertens, 16, pp. 53-59.
14. Luscher, T. F. (1994) The endothelium in hypertension: Bystander, target or mediator?. J Hypertens, 12, pp. S105-S116.
15. Panza, J. A., Casino, P. R., Kilcoyne, C. H. and Quyyumi, A. A. (1993) Role of endothelium-derived nitric oxide on the abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. Circulation, 87, pp. 1468-1474.
16. Taddei, S., Virdis, A., Mattei, P., Arzilli, F. and Salvetti, A. (1992) Endothelium-dependent forearm vasodilatation is reduced in normotensive subjects with familial history of hypertension. J Cardiovasc Pharmacol, pp. S193-S195.
17. Zizek, B., Poredos, P. and Videcnik, V. (2001) Endothelial dysfunction in hypertensive patients and in normotensive offspring of subjects with essential hypertension. Scientific letters. Heart, 85, pp. 215-217.
18. Julius, D. and Basbaum, A. I. (2001) Molecular mechanisms of nociception. Nature, 413, pp. 203-210.
19. Amara, S. G., Jonas, V., Rosenfeld, M. G., Ong, E. S. and Evans, R. M. (1982) Alternative RNA processing in calcitonin gene expression generates mRNA encoding different polypeptide products. Nature, 298, pp. 240-244.
20. Wimalawansa, S. J. (1996) Calcitonin gene-related peptide and its receptors: Molecular genetics, physiology, pathophysiology, and therapeutic potential. Endocrine Rev, 17, pp. 533-585.
21. Brain, S. D., Williams, T. J., Tippins, J. R., Morris, H. R. and Macintyre, I. (1985) Calcitonin gene-related peptide is a potent vasodilator. Nature, 313, pp. 54-56.
22. Poyner, D. R. (1992) Calcitonin gene-related peptide: Multiple actions, multiple receptors. Pharmacol Ther, 56, pp. 23-51.
23. Panza, J. A., Quyyumi, A. A., Brush Jr., J. E. and Epstein, S. E. (1990) Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Eng J Med, 323, pp. 22-27.
24. Troughton, R. W., Frampton, C. M., Yandle, T. G., Espiner, E. A., Nicholls, M. G. and Richards, A. M. (2000) Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet, 355, pp. 1126-1130.
25. Hirata, Y., Matsumoto, A., Aoyagi, T., Yamaoki, K., Komuro, I. and Suzuki, T. (2001) Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload. Cardiovasc Res, 51, pp. 585-591.
26. Wada, A., Tsutamoto, T., Matsuda, Y. and Kinoshita, M. (1994) Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors. Circulation, 89, pp. 2232-2240.